Raymond James Financial Services Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $2.55M | Sell |
108,969
-304
| -0.3% | -$7.11K | ﹤0.01% | 1603 |
|
2024
Q2 | $1.94M | Buy |
109,273
+1,853
| +2% | +$33K | ﹤0.01% | 1682 |
|
2024
Q1 | $1.63M | Buy |
107,420
+4,548
| +4% | +$69.2K | ﹤0.01% | 1749 |
|
2023
Q4 | $1.76M | Buy |
102,872
+4,011
| +4% | +$68.5K | ﹤0.01% | 1640 |
|
2023
Q3 | $826K | Sell |
98,861
-4,715
| -5% | -$39.4K | ﹤0.01% | 2020 |
|
2023
Q2 | $2.57M | Buy |
103,576
+1,291
| +1% | +$32.1K | ﹤0.01% | 1380 |
|
2023
Q1 | $1.54M | Buy |
102,285
+3,696
| +4% | +$55.6K | ﹤0.01% | 1644 |
|
2022
Q4 | $1.17M | Sell |
98,589
-659
| -0.7% | -$7.8K | ﹤0.01% | 1735 |
|
2022
Q3 | $588K | Sell |
99,248
-1,918
| -2% | -$11.4K | ﹤0.01% | 2149 |
|
2022
Q2 | $430K | Sell |
101,166
-12,187
| -11% | -$51.8K | ﹤0.01% | 2363 |
|
2022
Q1 | $1.08M | Buy |
113,353
+987
| +0.9% | +$9.39K | ﹤0.01% | 1893 |
|
2021
Q4 | $2.14M | Sell |
112,366
-30
| -0% | -$570 | ﹤0.01% | 1497 |
|
2021
Q3 | $3.74M | Sell |
112,396
-3,147
| -3% | -$105K | 0.01% | 1126 |
|
2021
Q2 | $4.48M | Sell |
115,543
-4,415
| -4% | -$171K | 0.01% | 1026 |
|
2021
Q1 | $5.78M | Sell |
119,958
-3,435
| -3% | -$166K | 0.01% | 839 |
|
2020
Q4 | $6.42M | Buy |
123,393
+4,400
| +4% | +$229K | 0.02% | 728 |
|
2020
Q3 | $3.18M | Sell |
118,993
-6,807
| -5% | -$182K | 0.01% | 955 |
|
2020
Q2 | $2.45M | Sell |
125,800
-6,823
| -5% | -$133K | 0.01% | 1021 |
|
2020
Q1 | $1.31M | Sell |
132,623
-27,826
| -17% | -$274K | 0.01% | 1078 |
|
2019
Q4 | $1.78M | Buy |
160,449
+6,745
| +4% | +$74.9K | 0.01% | 1222 |
|
2019
Q3 | $863K | Sell |
153,704
-242
| -0.2% | -$1.36K | ﹤0.01% | 1556 |
|
2019
Q2 | $1.33M | Sell |
153,946
-10,533
| -6% | -$91.1K | 0.01% | 1330 |
|
2019
Q1 | $1.32M | Buy |
164,479
+21,139
| +15% | +$170K | 0.01% | 1295 |
|
2018
Q4 | $588K | Sell |
143,340
-2,255
| -2% | -$9.25K | ﹤0.01% | 1566 |
|
2018
Q3 | $815K | Buy |
145,595
+1,359
| +0.9% | +$7.61K | ﹤0.01% | 1589 |
|
2018
Q2 | $1.9M | Buy |
144,236
+5,165
| +4% | +$67.9K | 0.01% | 1053 |
|
2018
Q1 | $1.98M | Buy |
139,071
+687
| +0.5% | +$9.76K | 0.01% | 938 |
|
2017
Q4 | $1.14M | Buy |
138,384
+57,280
| +71% | +$470K | 0.01% | 1219 |
|
2017
Q3 | $961K | Buy |
81,104
+31,958
| +65% | +$379K | 0.01% | 1338 |
|
2017
Q2 | $494K | Buy |
49,146
+4,240
| +9% | +$42.6K | ﹤0.01% | 1681 |
|
2017
Q1 | $523K | Buy |
44,906
+14,068
| +46% | +$164K | ﹤0.01% | 1540 |
|
2016
Q4 | $143K | Buy |
+30,838
| New | +$143K | ﹤0.01% | 2133 |
|